News
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...
The Puducherry administration is conducting enforcement raids on private drug retailers defying a ban on anti-TB drug sales.
19h
News Medical on MSNNew TB drugs show promise with fewer side effects than linezolidThe drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...
The Puducherry administration is conducting joint raids on private chemists selling anti-TB drugs in violation of a ban.
The Puducherry administration has intensified efforts to curb the unauthorized sale of anti-tuberculosis (TB) drugs by ...
Two international clinical studies led by PD Dr Norbert Heinrich at the Institute of Infectious Diseases and Tropical Medicine at LMU University Hospital Munich with international partners have shown ...
The Puducherry administration in alignment with the National Tuberculosis Elimination Programme implemented the ban on the ...
Sidebar Executive Summary. Mechanism of action. TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB.
Hosted on MSN9mon
Study identifies potential novel drug to treat tuberculosis - MSNMoreover, BPD-9 was effective against non-replicating (dormant) and intracellular M. tuberculosis, which are two key aspects that limit the effectiveness of current anti-TB drugs.
Centre may restrict distribution of anti-TB drugs through NTEP: Our Bureau, New Delhi Saturday, June 28, 2025, 08:00 Hrs [IST] The Central government may soon restrict the distrib ...
The Puducherry administration has launched raids against private drug retailers flouting the ban on sale of anti-tuberculosis drugs in contravention of norms. The joint enforcement raids are being ...
Sidebar Executive Summary. Mechanism of action. TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results